T1	Outcomes 299 310	vision loss
T2	Outcomes 549 558	Biosafety
T3	Outcomes 1019 1090	Treatment-emergent adverse events including blood chemistry metabolites
T4	Outcomes 1125 1184	supplementation elevated plasma and red blood cell-DHA 4.4-
T5	Outcomes 1354 1471	for vitamin A, vitamin E, platelet aggregation, antioxidant activity, lipoprotein cholesterol, or oxidized LDL levels
T6	Outcomes 1481 1487	0.14).
T7	Outcomes 1488 1502	Adverse events
T8	Outcomes 1518 1543	and not considered severe
T9	Outcomes 1548 1549	.
T10	Outcomes 1551 1615	gastrointestinal [GI] irritability, blood chemistry alterations)
T11	Outcomes 1647 1680	tolerate persistent GI discomfort
T12	Outcomes 1772 1797	with limited safety risks
T13	Outcomes 1820 1845	Nevertheless, GI symptoms
